This insider cluster is routine and non-material. No trading action warranted. Monitor for any upcoming SEC filings or clinical/regulatory updates for the company.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 27 $566.99entry
- T+1 · 7mo ago +0.37%α +0.86% · $569.11
- T+5 · 7mo ago +2.51%α +2.11% · $581.22
- T+20 · 6mo ago +2.02%α −2.94% · $578.43
- T+60 · 4mo ago −6.61%α −9.82% · $529.53
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three insiders at United Therapeutics (UTHR), including the CEO and CFO, sold a total of ~$3.48M in stock over a five-day period. All sales were preceded by derivative exercises (stock options) and represent routine cash-out transactions. At $24.9B market cap, the total sales are negligible (0.014% of market cap), carrying no material signal.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold 2,306 shares for ~$1.1M across multiple days.
- CFO James Edgemond sold 1,716 shares for ~$971K.
- Director Christopher Patusky sold 2,910 shares for ~$1.66M.
- All sales were accompanied by stock option exercises at $0 or near-market prices.
- Total open-market sales of ~$3.48M represent 0.014% of UTHR's $24.9B market cap.
Financial Impact
Total insider selling of $3.48M, immaterial relative to $24.9B market cap.
Risk Factors
- No material risks identified from this insider activity.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1777494766335 |
Track record
123 reports on UTHR
4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
- Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers